Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “RC18 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“RC18 – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an inve…
DUBLIN–(BUSINESS WIRE)–The “RC18 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“RC18 – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an inve…
LAVAL, Quebec–(BUSINESS WIRE)–#CDMO–Altasciences, a fully integrated early phase CRO/CDMO has started the expansion of their CDMO facility in Philadelphia, PA. The additional 35,000-square-foot building directly adjoins the current location, and wil…
LAVAL, Quebec–(BUSINESS WIRE)–#CDMO–Altasciences, a fully integrated early phase CRO/CDMO has started the expansion of their CDMO facility in Philadelphia, PA. The additional 35,000-square-foot building directly adjoins the current location, and wil…
DUBLIN–(BUSINESS WIRE)–The “TAK935 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“TAK935- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an i…
DUBLIN–(BUSINESS WIRE)–The “Perampanel – Emerging Insights and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“Perampanel – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights …
DUBLIN–(BUSINESS WIRE)–The “Linerixibat- Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“LINERIXIBAT- Emerging Insight and Market Forecast – 2030” report provides comprehensive insights about…
DUBLIN–(BUSINESS WIRE)–The “Esketamine DPI – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
Esketamine DPI is currently in Phase II of clinical trial study for Treatment-resistant Bipolar Dep…
2020 growth fueled by expansion into adult and pediatric care settings and the approval of an additional algorithm to power clinical decision-support software
BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for the i…
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announce…